Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics

Bannas, Peter, Hambach, Julia, Koch-Nolte, Friedrich·2017·Frontiers in Immunology

DOI 10.3389/fimmu.2017.01603

Cited by (572)

Items 101–200 of 572

T-cells engineered with a novel VHH-based chimeric antigen receptor against CD19 exhibit comparable tumoricidal efficacy to their FMC63-based counterparts
Fatemeh Nasiri, Pooria Safarzadeh Kozani, Fatemeh Rahbarizadeh · 2023 · Frontiers in Immunology
A comparison of the binding sites of antibodies and single-domain antibodies
Gemma L. Gordon, Henriette Capel, Bora Guloglu, Eve Richardson, Ryan Stafford, Charlotte Mary Deane · 2023 · Frontiers in Immunology
Enhanced sandwich immunoassay based on bivalent nanobody as an efficient immobilization approach for foodborne pathogens detection
Xingrui Liao, Yao Zhang, Yifan Liang, Lijie Zhang, Peng Wang, Juan Wei, Xuechi Yin, Jianlong Wang, Hong Wang, Yanru Wang · 2024 · Analytica Chimica Acta
Phage display technology and its impact in the discovery of novel protein-based drugs
Catherine J. Hutchings, Aaron K. Sato · 2024 · Expert Opinion on Drug Discovery
Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?
Poshmaal Dhar, Rasika M. Samarasinghe, Sarah L. Shigdar · 2020 · International Journal of Molecular Sciences
Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain
Lei He, Wanbo Tai, Jiangfan Li, Yuehong Chen, Yaning Gao, Junfeng Li, Shihui Sun, Yusen Zhou, Lanying Du, Guangyu Zhao · 2019 · Viruses
Multimeric single-domain antibody complexes protect against bunyavirus infections
Paul J. Wichgers Schreur, Sandra van de Water, Michiel M. Harmsen, Erick Bermúdez-Méndez, Dubravka Drabek, Frank G. Grosveld, Kerstin Wernike, Martin Beer, Andrea Aebischer, Olalekan Daramola et al. · 2020 · eLife
P2X receptors in cancer growth and progression
Francesco Di Virgilio, Valentina Vultaggio-Poma, Alba Clara Sarti · 2020 · Biochemical Pharmacology
Anti-NKG2D single domain-based antibodies for the modulation of anti-tumor immune response
Adeline Raynaud, Klervi Even-Desrumeaux, Laurent Vidard, Elise Termine, Daniel Baty, Patrick Chames, Emmanuelle Vigne, Brigitte Kerfélec · 2020 · OncoImmunology
A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine
Wei Ming Shi, Xiaomei Yang, Shenxia Xie, Dani Zhong, Xuandong Lin, Ziqiang Ding, Siliang Duan, Fengzhen Mo, Aiqun Liu, Shihua Yin et al. · 2021 · Cancer Letters
NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
Leona Raskova Kafkova, Joanna Maria Mierzwicka, Prosenjit Chakraborty, Petr Jakubec, Ondřej Fischer, Jozef Škarda, Petr Malý, Milan Raška · 2024 · Frontiers in Immunology
Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy
Haitao Pan, Jiayu Liu, Wentong Deng, Jieyu Xing, Qing Li, Zhong Wang · 2018 · International Journal of Nanomedicine
Pros and Cons of the Immunogenicity of Monoclonal Antibodies in Cancer Treatment: A Lesson from Autoimmune Diseases
Rossella Talotta, Francesco Rucci, Gianfranco L. Canti, Francesco Scaglione · 2019 · Immunotherapy
Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies
Joseph Tintelnot, Natalie Baum, Christoph Schultheiß, Friederike Braig, Marie Trentmann, Johannes Finter, William Fumey, Peter Bannas, Boris Fehse, Kristoffer Riecken et al. · 2019 · Molecular Cancer Therapeutics
Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective
Lucas, Andrew T., Moody, Amber, Schorzman, Allison N., Zamboni, William C. · 2021 · Antibodies
The Confluence of Innovation in Therapeutics and Regulation: Recent CMC Considerations
Lucas Gutierrez, Nina S. Cauchon, Twinkle R. Christian, Michael J. Giffin, Michael J. Abernathy · 2020 · Journal of Pharmaceutical Sciences
Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies
Sajad Najafi, Keywan Mortezaee · 2023 · Life Sciences
Current status and future expectations of nanobodies in oncology trials
Tessa De Pauw, Lynn De Mey, Jens M. Debacker, Geert Raes, Jo A. Van Ginderachter, Timo W.M. De Groof, Nick Devoogdt · 2023 · Expert Opinion on Investigational Drugs
Single-Domain Antibodies as Antibody–Drug Conjugates: From Promise to Practice—A Systematic Review
Víctor Manuel Medina Pérez, Marta Baselga, Alberto J. Schuhmacher · 2024 · Cancers
Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity
Stephan Menzel, Nicole Schwarz, Friedrich Haag, Friedrich Koch‐Nolte · 2018 · Frontiers in Pharmacology
Sandwich pair nanobodies, a potential tool for electrochemical immunosensing serum prostate-specific antigen with preferable specificity
Xin Liu, Dan Wang, Jinshen Chu, Yang Xu, Wenjun Wang · 2018 · Journal of Pharmaceutical and Biomedical Analysis
Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2
Mert Gölcük, Ahmet Yıldız, Mert Gür · 2022 · Journal of Molecular Graphics and Modelling
Influenza A Virus H7 nanobody recognizes a conserved immunodominant epitope on hemagglutinin head and confers heterosubtypic protection
Chen, Zhao-Shan, Huang, Hsiang-Chi, Wang, Xiangkun, Schön, Karin, Jia, Yane, Lebens, Michael, Besavilla, Danica F., Murti, Janarthan R., Ji, Yanhong, Sarshad, Aishe A. et al. · 2025 · Nature Communications
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
Pardis Mokhtary, Zeinab Pourhashem, Akram Abouie Mehrizi, Claudia Sala, Rino Rappuoli · 2022 · Biomedicines
Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2
Rocktotpal Konwarh · 2020 · Frontiers in Immunology
Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma
Maxime Fayon, Carolina Martínez-Cingolani, Audrey Abecassis, Nathalie Roders, Elisabeth Nelson, Caroline Choisy, Alexis Talbot, Armand Bensussan, Jean‐Paul Fermand, Bertrand Arnulf et al. · 2020 · Haematologica
Biophysical and biochemical characterization of a VHH-based IgG-like bi- and trispecific antibody platform
Lukas Pekar, Michael Busch, Bernhard Valldorf, Steffen C. Hinz, Lars Toleikis, Simon Krah, Stefan Zielonka · 2020 · mAbs
Engineered NK Cells Against Cancer and Their Potential Applications Beyond
Maria Karvouni, Marcos Vidal-Manrique, Andreas Lundqvist, Evren Alici · 2022 · Frontiers in Immunology
Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development
Bingxuan Li, Xiaohong Qin, Li-Zhi Mi · 2022 · Nanoscale
Exposing the molecular heterogeneity of glycosylated biotherapeutics
Schachner, Luis F., Mullen, Christopher, Phung, Wilson, Hinkle, Joshua D., Beardsley, Michelle Irwin, Bentley, Tracy, Day, Peter, Tsai, Christina, Sukumaran, Siddharth, Baginski, Tomasz et al. · 2024 · Nature Communications
Structural basis for chemically-induced homodimerization of a single domain antibody
Jean Lesné, Hung‐Ju Chang, Angélique De Visch, Matteo Paloni, Philippe Barthe, Jean‐François Guichou, Pauline Mayonove, Alessandro Barducci, Gilles Labesse, Jerome Bonnet et al. · 2019 · Scientific Reports
CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
Lisa A. King, Roeland Lameris, Tanja D. de Gruijl, Hans J. van der Vliet · 2018 · Frontiers in Immunology
Nanobody–siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells
Oleksandr Zavoiura, Bodo Brunner, Peter Casteels, Luciana Teixeira Zimmermann, Matthias Ozog, Carlo Boutton, Mike W. Helms, Timothy R. Wagenaar, Volker Adam, Josefine Peterka et al. · 2021 · Molecular Pharmaceutics
Single Domain Antibody application in bacterial infection diagnosis and neutralization
Qian Qin, Hao Liu, Wenbo He, Yucheng Guo, Jiaxin Zhang, Junjun She, Fang Zheng, Sicai Zhang, Serge Muyldermans, Yurong Wen · 2022 · Frontiers in Immunology
Recent electrochemical sensors and biosensors for toxic agents based on screen-printed electrodes equipped with nanomaterials
Masoud Negahdary, Wilson A. Ameku, Berlane Gomes Santos, Irlan S. Lima, Thawan Gomes de Oliveira, Mesaque Carvalho França, Lúcio Angnes · 2022 · Microchemical Journal
CD38 as theranostic target in oncology
Valentina Bocuzzi, Jessica Bridoux, Michelle Pirotte, Nadia Withofs, Roland Hustinx, Matthias D’Huyvetter, Jo Caers, Guillaume Marcion · 2024 · Journal of Translational Medicine
Nanobodies and Cancer: Current Status and New Perspectives
Alessandro Allegra, Vanessa Innao, Demetrio Gabriele Gerace, Doriana Vaddinelli, Andrea Gaetano Allegra, Caterina Musolino · 2018 · Cancer Investigation
Enhanced Anti-inflammatory Activity of Peptide–Gold Nanoparticle Hybrids upon Cigarette Smoke Extract Modification through TLR Inhibition and Autophagy Induction
Wei Gao, Lu Wang, Kun Wang, Liya Sun, Yafei Rao, Aying Ma, Min Zhang, Qiang Li, Hong Yu Yang · 2019 · ACS Applied Materials & Interfaces
Landscape of variable domain of heavy‐chain‐only antibody repertoire from alpaca
Zhui Tu, Xiaoqiang Huang, Jinheng Fu, Na Hu, Wei Hui Zheng, Yanping Li, Yang Zhang · 2020 · Immunology
Structural characterization of a novel GPVI-nanobody complex reveals a biologically active domain-swapped GPVI dimer
Alexandre Slater, Ying Di, Joanne C. Clark, Natalie J. Jooss, Eleyna M. Martin, Fawaz O. Alenazy, Mark Roland Thomas, Robert A.S. Ariëns, Andrew B. Herr, Natalie S. Poulter et al. · 2021 · Blood
Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective
Mengyu Li, Sen Mei, Yi Yang, Yuelei Shen, Lei Chen · 2022 · Antibody Therapeutics
Multifunctional NK Cell–Engaging Antibodies Targeting EGFR and NKp30 Elicit Efficient Tumor Cell Killing and Proinflammatory Cytokine Release
Katja Klausz, Lukas Pekar, Ammelie Svea Boje, Carina Lynn Gehlert, Steffen Krohn, Tushar Gupta, Yanping Xiao, Simon Krah, Rinat Zaynagetdinov, Britta Lipinski et al. · 2022 · The Journal of Immunology
Nanobody-guided targeted delivery of microRNA via nucleic acid nanogel to inhibit the tumor growth
Qiushuang Zhang, Fei Ding, Xinlong Liu, Jian Shen, Yue Su, Jiwen Qian, Xinyuan Zhu, Chuan Zhang · 2020 · Journal of Controlled Release
Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients
Linlin Cheng, Xiaomei Zhang, Yu Chen, Dan Wang, Dong Zhang, Songxin Yan, Hongye Wang, Meng Xiao, Te Liang, Haolong Li et al. · 2021 · Signal Transduction and Targeted Therapy
Mini-review: The market growth of diagnostic and therapeutic monoclonal antibodies – SARS CoV-2 as an example
Yasmine S. El Abd, Ashraf Abdou Tabll, Robert Smolić, Martina Smolić · 2021 · Human Antibodies
HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural studies of class IB phosphoinositide 3-kinases
Manoj Kumar Rathinaswamy, Kaelin D. Fleming, Udit Dalwadi, Els Pardon, Noah J Harris, Calvin K. Yip, Jan Steyaert, John E. Burke · 2021 · Structure
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
Ziqiang Ding, Shuyang Sun, Xuan Wang, Xiaomei Yang, Wei Shi, Xianing Huang, Shenxia Xie, Fengzhen Mo, Xiaoqiong Hou, Aiqun Liu et al. · 2023 · Journal of Hematology & Oncology
Single-domain antibodies as therapeutics for solid tumor treatment
Mingkai Wang, Tianlei Ying, Yanling Wu · 2024 · Acta Pharmaceutica Sinica B
Nanobody-based therapeutics against colorectal cancer: Precision therapies based on the personal mutanome profile and tumor neoantigens
Azita Moradi, Mohammad Mostafa Pourseif, Behzad Jafari, Sepideh Parvizpour, Yadollah Omidi · 2020 · Pharmacological Research
Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies
Suthimon Thumtecho, Nick J. Burlet, Anne Ljungars, Andreas H. Laustsen · 2023 · The Journal of venomous animals and toxins including tropical diseases
Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4
Katherine R. Griffiths, Uli Binder, William McDowell, Rita Tommasi, Mark Frigerio, William G. Darby, Chris G. Hosking, Lionel Renaud, Matthias Macháček, Peter M. Lloyd et al. · 2019 · mAbs
Treating infections with ionizing radiation: a historical perspective and emerging techniques
Bruce van Dijk, Justin V. C. Lemans, R. M. Hoogendoorn, Ekaterina Dadachova, John M. H. de Klerk, H. Charles Vogely, Harrie Weinans, Marnix G. E. H. Lam, Bart C. H. van der Wal · 2020 · Antimicrobial Resistance and Infection Control
Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using bi-Specific Antibodies and Therapeutic Vaccines
Ali Azadi, Alireza Golchini, Sina Delazar, Fatemeh Abarghooi Kahaki, Seyed Mohsen Dehnavi, Zahra Payandeh, Shirin Eyvazi · 2021 · Biological Procedures Online
The manufacturing considerations of bispecific antibodies
Dennis J. Underwood, Jeffrey Bettencourt, Zahra Jawad · 2022 · Expert Opinion on Biological Therapy
Formation of Tissue-Resident CD8+ T-Cell Memory
Feline E. Dijkgraaf, Lianne Kok, Ton N. Schumacher · 2021 · Cold Spring Harbor Perspectives in Biology
Nanobodies: a promising approach to treatment of viral diseases
Vitória Meneghetti Minatel, Carlos Roberto Prudêncio, Benedito Barraviera, Rui Seabra Ferreira · 2024 · Frontiers in Immunology
nanoBERT: a deep learning model for gene agnostic navigation of the nanobody mutational space
Johannes Thorling Hadsund, Tadeusz Satława, Bartosz Janusz, Lu Shan, Li Yong Zhou, Richard Röttger, Konrad Krawczyk · 2024 · Bioinformatics Advances
Nanobody‐based heavy chain antibodies and chimeric antibodies
Friedrich Koch‐Nolte · 2024 · Immunological Reviews
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Lisha Ou, Mekedlawit T. Setegne, Jeandele Elliot, Fangfang Shen, Laura M. K. Dassama · 2025 · Chemical Reviews
Development of a nanobody-based immunoassay for the sensitive detection of fibrinogen-like protein 1
Wanting Zhang, Tingting Liu, Man Wu, Xiaochen Chen, Han Li, Zhenzhong Shi, Yuying Li, Xi-yang Li, Haixing Xu, Likun Gong et al. · 2021 · Acta Pharmacologica Sinica
Enhancing Nanobody Immunoassays through Ferritin Fusion: Construction of a Salmonella-Specific Fenobody for Improved Avidity and Sensitivity
Xingrui Liao, Jiamin Wang, Bing Guo, Mengfan Bai, Yao Zhang, Gege Yu, Peng Wang, Juan Wei, Jianlong Wang, Xiyun Yan et al. · 2024 · Journal of Agricultural and Food Chemistry
Novel Delivery Systems for Checkpoint Inhibitors
Purushottam Lamichhane, Rahul R. Deshmukh, Julie K. Brown, Silvia Jakubski, Priyanka Parajuli, Todd A. Nolan, Dewan Saiful Raja, Mary Badawy, Thomas Yoon, Mark Zmiyiwsky et al. · 2019 · Medicines
Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo Mouse
Yumin Teng, Joyce L. Young, Bryan M. Edwards, Philip Hayes, Lorraine Thompson, Colette M. Johnston, Carolyn Edwards, Yun Sanders, Michele J. Writer, Debora Pinto et al. · 2019 · New Biotechnology
An Overview of the Current ADC Discovery Landscape
L. Nathan Tumey · 2019 · Methods in molecular biology
Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)
Sheng Yü, Xiong Gui, Shimei Zhao, Yanbo Tang, Hua Tang, Kaili Wang, Hongjing Liu, Ke Lan, Xiongjie Bi, Siliang Duan · 2020 · International Journal of Molecular Medicine
Nanobody-based CTLA4 inhibitors for immune checkpoint blockade therapy of canine cancer patients
Jonathan Marable, Damien Ruiz, Anil K. Jaiswal, Ritankar Bhattacharya, Robert J. Pantazes, Payal Agarwal, Amol S. Suryawanshi, Deepa Bedi, Amarjit Mishra, Bruce Frederic Smith et al. · 2021 · Scientific Reports
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
Angela I. Schriek, Marlies M. van Haaren, Meliawati Poniman, Gillian Dekkers, Arthur E. H. Bentlage, Marloes Grobben, Gestur Vidarsson, Rogier W. Sanders, Theo C. Verrips, Teunis B. H. Geijtenbeek et al. · 2022 · Frontiers in Immunology
Structural Classification of CDR-H3 in Single-Domain VHH Antibodies
Daisuke Kuroda, Kouhei Tsumoto · 2022 · Methods in molecular biology
Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles
Sara Colja, Ivana Jovčevska, Neja Šamec, Rok Romih, Alja Zottel · 2023 · Heliyon
Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update
Roa Alsajjan, Warren P. Mason · 2023 · Current Oncology
Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment
Hyukmin In, Minkyoung Park, Hyeonsik Lee, Kyung Ho Han · 2025 · Antibodies
Modulating ion channel function with antibodies and nanobodies
Catelijne Stortelers, Carolina Pinto-Espinoza, Diane Van Hoorick, Friedrich Koch‐Nolte · 2018 · Current Opinion in Immunology
Nanobodies: A New Approach for the Diagnosis and Treatment of Viral Infectious Diseases
Patrycja Sroga, David Safronetz, Derek Riley Stein · 2020 · Future Virology
Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications
Charles Shin, Sung Soo Kim, Yong Hwa Jo · 2021 · Molecular Therapy — Oncolytics
Nanobodies – Little helpers unravelling intracellular signaling
Teresa R. Wagner, Ulrich Rothbauer · 2021 · Free Radical Biology and Medicine
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du · 2024 · Journal of Nanobiotechnology
Transforming nanobodies into high-precision tools for protein function analysis
Jan Gettemans, Brian De Dobbelaer · 2020 · American Journal of Physiology-Cell Physiology
Discovery of Antivirals Using Phage Display
Esen Sokullu, Marie‐Soleil Gauthier, Benoit Coulombe · 2021 · Viruses
An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
Hongchuan Liu, Rui Wang, Duopeng An, Hui Liu, Fan Ye, Baoxian Li, Jing Zhang, Peixiang Liu, Xuyao Zhang, Sheng Yao et al. · 2021 · International Immunopharmacology
Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells
Julia Hambach, William Fumey, Tobias Stähler, Anna Josephine Gebhardt, Gerhard Adam, Katja Christina Weisel, Friedrich Koch‐Nolte, Peter Bannas · 2022 · Frontiers in Immunology
Oligoclonal selection of nanobodies targeting vascular endothelial growth factor
Mehrdad Ahadi, Haniyeh Ghasemian, Mahdi Behdani, Fatemeh Kazemi‐Lomedasht · 2018 · Journal of Immunotoxicology
Selection of Functional Intracellular Nanobodies
James Woods · 2019 · SLAS DISCOVERY
Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies
Levin Schriewer, Kerstin Schütze, Katharina Petry, Julia Hambach, William Fumey, Julia Koenigsdorf, Natalie Baum, Stephan Menzel, Björn Rissiek, Kristoffer Riecken et al. · 2020 · Theranostics
Nanobody assemblies with fully flexible topology enabled by genetically encoded tetrazine amino acids
Elise M. Van Fossen, Riley M. Bednar, Subhashis Jana, Rachel Franklin, Joseph S. Beckman, P. Andrew Karplus, Ryan A. Mehl · 2022 · Science Advances
Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
Hamideh Raeisi, Masoumeh Azimirad, Ali Nabavi-Rad, Hamid Asadzadeh Aghdaei, Abbas Yadegar, Mohammad Reza Zali · 2022 · Frontiers in Immunology
Central Nervous System Delivery of Antibodies and Their Single-Domain Antibodies and Variable Fragment Derivatives with Focus on Intranasal Nose to Brain Administration
Arghavan Soleimanizadeh, Heiko Dinter, Katharina Schindowski · 2021 · Antibodies
Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons
Soha S. Rizk, Dina Mohamed Moustafa, Shahira A. ElBanna, Hanzada T. Nour El‐Din, Ahmed Sherif Attia · 2024 · World Journal of Microbiology and Biotechnology
A general strategy to inhibit serine protease by targeting its autolysis loop
Longguang Jiang, Cai Yuan, Mingdong Huang · 2021 · The FASEB Journal
Data mining patented antibody sequences
Konrad Krawczyk, Andrew G. Buchanan, Paolo Marcatili · 2021 · mAbs
Development of novel-nanobody-based lateral-flow immunochromatographic strip test for rapid detection of recombinant human interferon α2b
Xi Qin, Maoqin Duan, Dening Pei, Jian Lin, Lan Wang, Peng Zhou, Wenrong Yao, Ying Guo, Xiang Li, Tao Lei et al. · 2021 · Journal of Pharmaceutical Analysis
Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article
AbdulRahman A. Saied, Asmaa A. Metwally, Moses Alobo, Jaffer Shah, Khan Sharun, Kuldeep Dhama · 2022 · International Journal of Surgery
AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of de novo humanized and sequence-optimized single domain antibodies: a prospective case study
Paul Arras, Han Byul Yoo, Lukas Pekar, Thomas Clarke, Lukas Friedrich, Christian J. Schröter, Jennifer Schanz, Jason Tonillo, Vanessa Siegmund, Achim Doerner et al. · 2023 · Frontiers in Molecular Biosciences
Single-domain antibody C7b for address delivery of nanoparticles to HER2-positive cancers
Yuri A. Vorotnikov, Evgeniya D. Novikova, Anastasiya O. Solovieva, Шаньшин Даниил Васильевич, Alphiya R. Tsygankova, Д. Н. Щербаков, Olga A. Efremova, Michael A. Shestopalov · 2020 · Nanoscale
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
Alessandra Romano, Paola Storti, Valentina Marchica, Grazia Scandura, Laura Notarfranchi, Luisa Craviotto, Francesco Di Raimondo, Nicola Giuliani · 2021 · Frontiers in Oncology
Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment
Xiaohan Guo, Yi Wu, Xue Ying, Na Xie, Guobo Shen · 2023 · Frontiers in Immunology
A novel approach to produce phage single domain antibody fragments for the detection of gluten in foods
Aina García-García, Raquel Madrid, Isabel González, Teresa Garcı́a, Rosario Martı́n · 2020 · Food Chemistry
Harnessing the therapeutic potential of antibodies targeting connexin hemichannels
Damiano Buratto, Viola Donati, Francesco Zonta, Fabio Mammano · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Radiolabeled nanobodies for tumor targeting: From bioengineering to imaging and therapy
Majid Piramoon, Fatemeh Khodadust, Seyed Jalal Hosseinimehr · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Anti-CD19 CAR T cells potently redirected to kill solid tumor cells
Christine M. Ambrose, Lihe Su, Lan Wu, Fay J. Dufort, Thomas Sanford, Alyssa Birt, Benjamin J. Hackel, Andreas A. Hombach, Hinrich Abken, Roy R. Lobb et al. · 2021 · PLoS ONE
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies
Maxwell A. Stefan, Yooli Kim Light, Jennifer L. Schwedler, Peter R. McIlroy, Colleen M. Courtney, Edwin A. Saada, Christine E. Thatcher, Ashlee M. Phillips, Feliza A. Bourguet, Catherine M. Mageeney et al. · 2021 · mAbs